冠状动脉聚合物内支架市场－全球产业规模、份额、趋势、机会和预测（按类型、应用、地区和竞争情况细分，2020-2030 年）

2024 年全球冠状动脉聚合物内支架市场价值为 48.2 亿美元，预计在预测期内将实现稳定成长，到 2030 年的年复合成长率(CAGR) 为 5.20%。该市场代表了医疗保健行业内一个充满活力且快速发展的领域，在冠状动脉疾病 (CAD) 的治疗中发挥关键作用。

冠状动脉疾病的特征是向心臟供血的动脉变窄，它仍然是全世界死亡和残疾的主要原因。聚合物支架已成为一种变革性的解决方案，为传统冠状动脉绕道手术提供了微创替代方案。这些先进的医疗设备是由生物相容性聚合物製成的小型可扩展管，被插入阻塞或狭窄的冠状动脉以恢復和维持血流。

由于不健康饮食、久坐行为和全球人口老化等生活方式因素，CAD 盛行率不断上升，这是推动市场扩张的主要因素。聚合物内支架通常透过经皮冠状动脉介入治疗（PCI）进行部署，通常称为血管成形术，与手术方法相比，它由于其效率高且恢復时间短而被广泛采用。

技术创新继续塑造这个市场，推动具有改进的药物洗脱能力、生物可吸收材料和增强的输送机制的下一代聚合物内支架的开发。这些进步旨在降低血管再狭窄（血管重新变窄）和血栓形成（血栓形成）的风险，同时支持更快的组织癒合和整合。此外，人们对心血管风险因素的认识不断提高以及新兴市场医疗保健基础设施的加强也促进了该行业的全球扩张。

关键市场驱动因素

冠状动脉疾病（CAD）盛行率上升

主要市场挑战

监管壁垒

主要市场趋势

微创手术的进展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球冠状动脉聚合物内支架市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（PLGA、PLLA、PDLA、脱氨酪胺聚碳酸酯eucatech）
  • 依用途（急性心肌梗塞、急性血管阻塞、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美冠状动脉聚合物内支架市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲冠状动脉聚合物内支架市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太冠状动脉聚合物内支架市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲冠状动脉聚合物内支架市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲冠状动脉聚合物内支架市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Eucatech AG
• MicroPort Scientific Corporation
• Rontis Medical
• Meril Life Sciences
• Alvimedica Medical Technologies
• InSitu Technologies
• Elixir Medical
• SINOMED Inc
• Amaranth Medical Inc
• Amg International

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Coronary Artery Polymer Endostents Market was valued at USD 4.82 billion in 2024 and is projected to experience stable growth over the forecast period, with a compound annual growth rate (CAGR) of 5.20% through 2030. This market represents a dynamic and rapidly evolving segment within the healthcare industry, playing a critical role in the treatment of coronary artery disease (CAD).

Coronary artery disease, characterized by the narrowing of the arteries that supply blood to the heart, continues to be a leading cause of death and disability worldwide. Polymer endostents have emerged as a transformative solution, offering a minimally invasive alternative to conventional coronary artery bypass surgery. These advanced medical devices-small, expandable tubes made from biocompatible polymers-are inserted into blocked or narrowed coronary arteries to restore and maintain blood flow.

The increasing prevalence of CAD, driven by lifestyle factors such as unhealthy diets, sedentary behavior, and an aging global population, is a primary factor fueling market expansion. Polymer endostents are typically deployed through percutaneous coronary intervention (PCI), commonly known as angioplasty, a widely adopted procedure due to its efficiency and shorter recovery times compared to surgical approaches.

Technological innovations continue to shape this market, leading to the development of next-generation polymer endostents with improved drug-eluting capabilities, bioabsorbable materials, and enhanced delivery mechanisms. These advancements are designed to reduce the risks of restenosis (vessel re-narrowing) and thrombosis (blood clot formation) while supporting faster tissue healing and integration. Additionally, rising awareness of cardiovascular risk factors and the strengthening of healthcare infrastructure in emerging markets are contributing to the sector's global expansion.

Key Market Drivers

Rising Prevalence of Coronary Artery Disease (CAD)

The growing incidence of CAD is a major driver behind the expansion of the Coronary Artery Polymer Endostents Market. CAD is the foremost cause of mortality globally, responsible for an estimated 17.9 million deaths annually-approximately 85% of which are due to heart attacks and strokes. According to the World Health Organization (WHO), addressing risk factors such as hypertension, obesity, and diabetes is essential to reducing premature deaths and alleviating the global healthcare burden caused by cardiovascular diseases.

In 2022, the estimated number of active CAD cases reached 315 million worldwide, highlighting the scale of this public health challenge. Sedentary lifestyles, poor dietary habits, smoking, and a rising incidence of comorbid conditions have all contributed to this increase. Consequently, there is a growing demand for effective and minimally invasive treatment options like coronary artery polymer endostents.

These stents offer a less invasive solution compared to traditional bypass surgery, functioning as internal scaffolds to keep arteries open while also delivering drugs that help prevent complications such as restenosis and thrombosis. Their use translates into shorter hospital stays, quicker recovery times, and fewer post-operative complications.

As healthcare systems increasingly focus on cost-effective and efficient treatment methods, polymer endostents are gaining favor for their clinical effectiveness and economic viability. Their minimally invasive nature aligns with the healthcare industry's shift toward outpatient care and same-day discharge protocols. Furthermore, the aging population-more vulnerable to CAD-underscores the importance of expanding access to such advanced treatment solutions.

Key Market Challenges

Regulatory Barriers

Despite significant technological progress and the increasing importance of polymer endostents in CAD management, the market faces several regulatory challenges that may impede growth. The medical device approval landscape is complex and varies significantly across global regions. Regulatory authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national bodies impose distinct and often rigorous requirements for market access.

This lack of regulatory harmonization results in extended approval timelines and elevated development costs. Manufacturers must navigate a demanding approval process, which includes extensive preclinical and clinical testing, as well as comprehensive documentation. Although these requirements ensure patient safety and product efficacy, they also delay commercialization and inflate operational expenses.

Moreover, regional discrepancies in regulatory expectations compel manufacturers to tailor their submissions for individual markets, adding further complexity to global expansion efforts. This fragmented regulatory landscape remains a key obstacle to the broader adoption and availability of coronary artery polymer endostents.

Key Market Trends

Advancement of Minimally Invasive Procedures

The increasing adoption of minimally invasive procedures is significantly contributing to the growth of the Coronary Artery Polymer Endostents Market. These approaches have revolutionized the treatment paradigm for CAD, offering both patients and providers a less intrusive and more efficient alternative to traditional surgery.

Polymer endostents are central to these procedures, deployed through catheter-based techniques rather than open-heart surgery. This method minimizes physical trauma, leading to less pain, reduced blood loss, and faster recovery. Patients benefit from shorter hospital stays and a quicker return to daily activities, ultimately improving quality of life.

Clinically, minimally invasive techniques enhance procedural precision, allowing cardiologists to navigate complex vascular anatomies with greater ease and safety. These procedures also tend to have fewer complications and shorter durations, making them increasingly attractive in busy healthcare settings.

The trend toward minimally invasive interventions, combined with ongoing product innovation and improved patient outcomes, is expected to continue propelling the coronary artery polymer endostents market forward.

Key Market Players

• Eucatech AG
• MicroPort Scientific Corporation
• Rontis Medical
• Meril Life Sciences
• Alvimedica Medical Technologies
• InSitu Technologies
• Elixir Medical
• SINOMED Inc
• Amaranth Medical Inc
• Amg International

Report Scope:

In this report, the Global Coronary Artery Polymer Endostents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Coronary Artery Polymer Endostents Market, By Type:

• PLGA
• PLLA
• PDLA
• Deamination Tyramine Polycarbonateeucatech

Coronary Artery Polymer Endostents Market, By Application:

• Acute Myocardial Infarction
• Acute Vascular Blockage
• Other

Coronary Artery Polymer Endostents Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Coronary Artery Polymer Endostents Market.

Available Customizations:

Global Coronary Artery Polymer Endostents market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Coronary Artery Polymer Endostents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (PLGA, PLLA, PDLA, Deamination Tyramine Polycarbonateeucatech)
  • 5.2.2. By Application (Acute Myocardial Infarction, Acute Vascular Blockage, Other)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Coronary Artery Polymer Endostents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Coronary Artery Polymer Endostents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Coronary Artery Polymer Endostents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Coronary Artery Polymer Endostents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Coronary Artery Polymer Endostents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Coronary Artery Polymer Endostents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Coronary Artery Polymer Endostents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Coronary Artery Polymer Endostents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Coronary Artery Polymer Endostents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Coronary Artery Polymer Endostents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Coronary Artery Polymer Endostents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Coronary Artery Polymer Endostents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Coronary Artery Polymer Endostents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Coronary Artery Polymer Endostents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Coronary Artery Polymer Endostents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Coronary Artery Polymer Endostents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Coronary Artery Polymer Endostents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Coronary Artery Polymer Endostents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Coronary Artery Polymer Endostents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Coronary Artery Polymer Endostents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Coronary Artery Polymer Endostents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Coronary Artery Polymer Endostents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Coronary Artery Polymer Endostents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Coronary Artery Polymer Endostents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Eucatech AG
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. MicroPort Scientific Corporation
• 15.3. Rontis Medical
• 15.4. Meril Life Sciences
• 15.5. Alvimedica Medical Technologies
• 15.6. InSitu Technologies
• 15.7. Elixir Medical
• 15.8. SINOMED Inc
• 15.9. Amaranth Medical Inc
• 15.10. Amg International

16. Strategic Recommendations

17. About Us & Disclaimer